141 related articles for article (PubMed ID: 38395903)
1. Protocol for the ONLOOP trial: pragmatic randomized trial evaluating a province-wide system of personalized reminders for evidence-based surveillance tests in adult survivors of childhood cancer in Ontario.
Shuldiner J; Lam E; Shah N; Grimshaw J; Desveaux L; Heisey R; Taccone MS; Taljaard M; Thavorn K; Hodgson D; Gupta S; Lofters A; Ivers N; Nathan PC
Implement Sci; 2024 Feb; 19(1):19. PubMed ID: 38395903
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal adherence to surveillance for late effects of cancer treatment: a population-based study of adult survivors of childhood cancer.
Shuldiner J; Sutradhar R; Lau C; Shah N; Lam E; Ivers N; Nathan PC
CMAJ; 2024 Mar; 196(9):E282-E294. PubMed ID: 38467416
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review.
Zabih V; Kahane A; O'Neill NE; Ivers N; Nathan PC
J Cancer Surviv; 2019 Oct; 13(5):713-729. PubMed ID: 31338733
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
7. Developing a Provincial Surveillance and Support System for Childhood Cancer Survivors: Multiphase User-Centered Design Study.
Shuldiner J; Shah N; Reis C; Chalmers I; Ivers N; Nathan P
JMIR Hum Factors; 2022 Sep; 9(3):e37606. PubMed ID: 36099013
[TBL] [Abstract][Full Text] [Related]
8. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
9. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.
McBride ML; Groome PA; Decker K; Kendell C; Jiang L; Whitehead M; Li D; Grunfeld E;
BMC Cancer; 2019 Jul; 19(1):659. PubMed ID: 31272420
[TBL] [Abstract][Full Text] [Related]
10. Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): protocol for a pragmatic, cluster-randomized controlled trial.
Ivers NM; Schwalm JD; Grimshaw JM; Witteman H; Taljaard M; Zwarenstein M; Natarajan MK
Implement Sci; 2012 Jun; 7():54. PubMed ID: 22682691
[TBL] [Abstract][Full Text] [Related]
11. Impact of the model of long-term follow-up care on adherence to guideline-recommended surveillance among survivors of adolescent and young adult cancers.
Kagramanov D; Sutradhar R; Lau C; Yao Z; Pole JD; Baxter NN; Gupta S; Nathan PC
Cancer Med; 2021 Aug; 10(15):5078-5087. PubMed ID: 34128353
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. The BETTER WISE protocol: building on existing tools to improve cancer and chronic disease prevention and screening in primary care for wellness of cancer survivors and patients - a cluster randomized controlled trial embedded in a mixed methods design.
Manca DP; Fernandes C; Grunfeld E; Aubrey-Bassler K; Shea-Budgell M; Lofters A; Campbell-Scherer D; Sopcak N; O'Brien MA; Meaney C; Moineddin R; McBrien K; Salvalaggio G; Krueger P
BMC Cancer; 2018 Sep; 18(1):927. PubMed ID: 30257655
[TBL] [Abstract][Full Text] [Related]
14. Mailed Letter Versus Phone Call to Increase Uptake of Cancer Screening: A Pragmatic, Randomized Trial.
Kiran T; Davie S; Moineddin R; Lofters A
J Am Board Fam Med; 2018; 31(6):857-868. PubMed ID: 30413542
[TBL] [Abstract][Full Text] [Related]
15. Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
Vives N; Farre A; Ibáñez-Sanz G; Vidal C; Binefa G; Milà N; Pérez-Lacasta MJ; Travier N; Benito L; Espinàs JA; Bagaria G; Garcia M
PLoS One; 2021; 16(1):e0245806. PubMed ID: 33481914
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
[TBL] [Abstract][Full Text] [Related]
17. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
18. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent.
Salloum RG; Hornbrook MC; Fishman PA; Ritzwoller DP; O'Keeffe Rossetti MC; Elston Lafata J
Cancer; 2012 Nov; 118(22):5644-51. PubMed ID: 22434568
[TBL] [Abstract][Full Text] [Related]
19. Nutritional interventions for survivors of childhood cancer.
Cohen JE; Wakefield CE; Cohn RJ
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
